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AbstrAct
Introduction and objective Heredity of type 2 diabetes 
mellitus (T2DM) is associated with greater risk for 
developing T2DM. Thus, individuals who have a first- 
degree relative with T2DM (FDRT) provide a natural model 
to study factors of susceptibility towards development of 
T2DM, which are poorly understood. Emerging key players 
in T2DM pathophysiology such as adverse oxidative stress 
and inflammatory responses could be among possible 
mechanisms that predispose FDRTs to develop T2DM. 
Here, we aimed to examine the role of oxidative stress and 
inflammatory responses as mediators of this excess risk 
by studying dynamic postprandial responses in FDRTs.
Research design and methods In this open- label 
case- control study, we recruited normoglycemic men 
with (n=9) or without (n=9) a family history of T2DM. We 
assessed plasma glucose, insulin, lipid profile, cytokines 
and F2- isoprostanes, expression levels of oxidative and 
inflammatory genes/proteins in circulating mononuclear 
cells (MNC), myotubes and adipocytes at baseline (fasting 
state), and after consumption of a carbohydrate- rich liquid 
meal or insulin stimulation.
Results Postprandial glucose and insulin responses 
were not different between groups. Expression of oxidant 
transcription factor NRF2 protein (p<0.05 for myotubes) 
and gene (pgroup=0.002, ptime×group=0.016), along with its 
target genes TXNRD1 (pgroup=0.004, ptime×group=0.007), GPX3 
(pgroup=0.011, ptime×group=0.019) and SOD-1 (pgroup=0.046 and 
ptime×group=0.191) was upregulated in FDRT- derived MNC 
after meal ingestion or insulin stimulation. Synergistically, 
expression of target genes of inflammatory transcription 
factor nuclear factor kappa B such as tumor necrosis 
factor alpha (pgroup=0.001, ptime×group=0.007) was greater in 
FDRT- derived MNC than in non- FDRT- derived MNC after 
meal ingestion or insulin stimulation.
Conclusions Our findings shed light on how heredity of 
T2DM confers increased susceptibility to oxidative stress 
and inflammation. This could provide early insights into 
the underlying mechanisms and future risk of FDRTs for 
developing T2DM and its associated complications.
InTRoduCTIon
Oxidative stress and inflammation induced by 
nutritional excess can contribute to impaired 
insulin receptor signaling in insulin- sensitive 
target tissues,1–5 leading to insulin resistance, 
development of type 2 diabetes mellitus 
(T2DM) and diabetic vascular complica-
tions.6–8 Defects in insulin signaling are 
inherited, and insulin action in offspring of 
patients with T2DM has been shown to be the 
significance of this study
What is already known about this subject?
 ► Oxidative stress and inflammation can interfere with 
insulin signaling and contribute to the development 
of insulin resistance, type 2 diabetes mellitus (T2DM) 
and its associated complications.
 ► Heredity of T2DM is a major risk factor for develop-
ing T2DM but little is known of the factors mediating 
the increased risk.
What are the new findings?
 ► Individuals with a first- degree relative with T2DM 
(FDRT) show increased oxidative stress and inflam-
mation in response to a high- carbohydrate challenge 
as compared with non- FDRT individuals. These ob-
servations are independent of age, body mass index 
and insulin sensitivity.
 ► The adverse oxidative stress and inflammatory re-
sponses following the meal challenge are observed 
in circulating mononuclear blood cells. Moreover, 
when an insulin stimulus was used to mimic the 
meal challenge in vitro, myotubes and adipocytes 
isolated from FDRT individuals also showed in-
creased oxidative stress and inflammatory respons-
es as compared with non- FDRT individuals.
 ► Individuals with heredity of T2DM are susceptible to 
adverse dynamic postprandial stress responses.
How might these results change the focus of 
research or clinical practice?
 ► Our observation that heredity of T2DM confers in-
creased susceptibility to oxidative stress and inflam-
mation following a high- carbohydrate meal could 
provide early insights into the underlying mecha-
nisms and future risk of FDRTs for developing T2DM 
and its complications.
2 BMJ Open Diab Res Care 2020;8:e000945. doi:10.1136/bmjdrc-2019-000945
Genetics/Genomes/Proteomics/Metabolomics
best predictor for development of the disease.9–11 The 
cumulative incidence of T2DM among individuals with a 
first- degree relative with T2DM (FDRT) is 40%–76%.12 13 
Thus, normoglycemic individuals with heredity of T2DM 
constitute an ideal natural model for studying early 
pathophysiological events during the development and 
progression of T2DM. In the basal state, FDRTs demon-
strate inherited defects in muscle fiber composition and 
function, for example, reversal of type I (oxidative) to 
type II (glycolytic) fiber ratio14 and compromised muscle 
mitochondrial biogenesis and oxidative metabolism.15 16
Although a family history of T2DM is an established risk 
factor for development of T2DM, the factors mediating 
this excess risk remain poorly understood. Major T2DM 
risk factors such as anthropometric measures, lifestyle 
risk factors and genetic risk score all together have been 
shown to explain only 13% of the risk of T2DM associated 
with family history.17 Accumulating evidence suggests an 
association of heredity of T2DM and enhanced levels of 
systemic inflammatory and oxidative stress in the fasted 
state,18–20 which is aggravated after an acute high- fat meal 
challenge.21 22 Cumulative perturbations in the regula-
tion of oxidative stress and inflammatory responses to 
meal ingestion may contribute to the greater risk for 
T2DM and its cardiovascular complications among FDRT 
individuals.23 24
We have previously shown that a single meal rich in 
carbohydrate, but not fat or protein, elicits adverse 
inflammatory, metabolic, hormonal as well as oxidative 
stress responses in obese insulin- resistant individuals 
with normal glucose tolerance.25–28 This work led us to 
enquire whether a high- carbohydrate meal challenge 
could also induce distinct oxidative and inflammatory 
responses in another high- risk metabolic phenotype, 
namely FDRTs. Here, we aimed to examine the role of 
oxidative stress and inflammatory responses as mediators 
of excess risk of T2DM in FDRTs by studying dynamic 
postprandial responses in them. This could provide early 
insights into underlying mechanisms and future risk of 
FDRTs for developing T2DM.
To this end, we characterized these responses in young, 
overweight and obese individuals with or without a family 
history of T2DM before and after a test meal. We investi-
gated the effects of a single meal rich in carbohydrate on 
the expression profile of oxidative stress and inflamma-
tory genes, proteins and metabolites in circulating mono-
nuclear cells (MNC), myotubes, adipocytes and plasma.
ReseaRCH desIgn and meTHods
Participants
This study was conducted at the National University of 
Singapore School of Medicine, Singapore. Study partic-
ipants were recruited from October 2013 until February 
2016. Data collection was carried out from March 2015 
to November 2018. We studied normoglycemic (fasting 
blood glucose <5.6 mmol/L) Chinese men with (n=9) or 
without (n=9) a first- degree relative with type 2 diabetes 
(age: 21–40 years, body mass index (BMI): 23.0–27.5 kg/
m2). The study participants were selected from a larger 
group of subjects and matched one to one for BMI 
and insulin sensitivity (homeostatic model assessment 
of insulin resistance). Subjects in both groups had no 
history of smoking, alcohol consumption, overt disease, 
medication intake, atypical dietary habits, hospitalization 
or surgery in the last 6 months and weight change >5% 
in the last 3 months.
experimental design
This was an open- label case- control study. Fasting blood 
samples were collected to measure serum insulin, 
glucose, non- esterified fatty acid (NEFA) concentra-
tions, and lipid profile. Eligible participants, after having 
fasted overnight and abstained from vigorous physical 
activity for 24 hours, ingested a carbohydrate- rich liquid 
mixed meal (~600 kcal; 57% carbohydrate, 29% fat and 
14% protein; ~400 mL; Ensure Plus, Abbott Nutrition), 
within 5 min. Fasting and postprandial (0, 30, 60, 90, 
120, 180, 240, 300, and 360 min) venous blood samples 
were collected for the measurement of glucose, insulin, 
triglyceride (TG) and NEFA concentrations. Fasting 
and postprandial (360 min) midstream urine samples 
were also collected for the measurement of urinary F2- 
isoprostanes, a biomarker of oxidative stress- induced 
lipid peroxidation.
To isolate MNCs by density gradient centrifugation, 
9 mL of blood was collected into tubes containing EDTA 
at 0, 120, and 360 min.
Skeletal muscle and adipose tissue samples were taken 
from lateral aspect of the upper thigh of consenting 
subjects (n=5 per group) in the fasted state, as previ-
ously described.5 Approximately 500 mg of subcutaneous 
adipose tissue and 200 mg of muscle tissue were excised 
and immediately placed in phosphate- buffered saline 
(PBS) and processed as detailed below.
Human preadipocyte isolation and primary culture
Subcutaneous white adipose tissue samples were minced 
and digested with collagenase (1 mg/mL) (Sigma- 
Aldrich, Israel) and supplemented with 2% bovine 
serum albumin (Sigma- Aldrich, St Louis, MO, USA) at 
37°C for 1 hour. Digested tissue was then filtered through 
a 100 µm cell strainer (SPL Life Sciences, Gyeonggi- do, 
Korea), followed by several washes in PBS, and centrifu-
gation (400 g for 5 min).
The stromal vascular fraction (SVF) containing pread-
ipocytes was then resuspended in growth medium 
consisting of high- glucose Dulbecco’s modified Eagle’s 
medium (DMEM) (Hyclone- GE Healthcare, Logan, 
UT, USA), 15% fetal bovine serum (FBS) (Hyclone- GE 
Healthcare), 1% non- essential amino acids (Gibco, 
Grand Island, NY, USA), 1% penicillin/streptomycin 
(PS) (Hyclone- GE Healthcare) and 5 ng/mL fibroblast 
growth factor (Gibco, Frederick, MD, USA). Cells were 
grown at 37°C and 5% CO2.
3BMJ Open Diab Res Care 2020;8:e000945. doi:10.1136/bmjdrc-2019-000945
Genetics/Genomes/Proteomics/Metabolomics
When preadipocytes displayed fibroblastic morphology, 
they were differentiated using Lonza’s PGM-2 Adipocyte 
Differentiation Kit (catalog number PT8002, Lonza, 
Basel, Switzerland) for 14 days following the manufactur-
er’s protocol. Mature adipocytes were then serum starved 
for 3 hours after which cells were stimulated with 100 
and 1000 nM insulin (Gibco, Grand Island, NY, USA) for 
10–30 min. Cells were subsequently harvested for gluta-
thione (GSH) assay, RNA and protein.
Human myoblast isolation and primary culture
Skeletal muscle tissue biopsies collected in PBS were 
digested with collagenase (1 mg/mL) (Sigma- Aldrich, 
Israel) for 30–45 min at 37°C to isolate myoblast cells. 
Tissue digest was passed through a 100 µm cell strainer 
(SPL Life Sciences), washed several times in PBS, and 
pelleted down at 2200 g for 10 min. The cell pellet was 
then resuspended in myoblast growth media consisting 
of DMEM (Hyclone- GE Healthcare) supplemented with 
20% FBS (Hyclone- GE Healthcare), 10% horse serum 
(Gibco, New Zealand), and 1% PS (Hyclone- GE Health-
care) and plated in an uncoated cell culture dish for 
2 hours at 37°C and 5% CO2.
Thereafter, the cell suspension containing myoblasts 
was transferred to a Matrigel- coated (Corning, Bedford, 
MA, USA) cell culture dish and grown to 80% confluence. 
Differentiation of myoblasts into myotubes was initiated 
using differentiation medium (DMEM supplemented 
with 2% horse serum and 1% PS) for 7 days in Matrigel- 
coated plates. Following differentiation, myotubes were 
serum starved for 3 hours, and subsequently underwent 
stimulation with 100 and 1000 nM insulin (Gibco, Grand 
Island, NY, USA) for 10–30 min, after which they were 
harvested for GSH assay, RNA and protein.
Biochemical analyses
Plasma glucose and TG concentrations were measured by 
using enzymatic and colorimetric methods, respectively 
(AU5800, Beckman Coulter, California, USA). Serum 
insulin was measured by using a chemiluminescence 
immunoassay (ADVIA Centaur, Siemens Healthcare 
Diagnostics, Hamburg, Germany). These analyses were 
carried out by a laboratory accredited by the College of 
American Pathologists. Plasma NEFA was measured at 
Mayo Medical Laboratories (Rochester, MN, USA) using 
an enzymatic colorimetric method (Cobas 6000, Roche 
Diagnostics, Indianapolis, USA).
Plasma interleukin-6 (IL-6) (catalog number HS600B) 
concentration was measured using Quantikine high- 
sensitivity ELISA kit (R&D Systems, Minneapolis, MN, 
USA). Plasma tumor necrosis factor alpha (TNFα) 
concentration was measured using an ultrasensitive 
ELISA kit (catalog number 45- TNFHUU- E01, Alpco 
Diagnostics, Salem, NH, USA). Intra- assay and interassay 
coefficients of variations for IL-6 and TNFα were <10%.
Plasma total (free and esterified) and urinary free F2- 
isoprostanes were measured using a method described 
previously.29 30 The isoprostane levels in plasma and urine 
were normalized against arachidonic acid and creatinine 
levels, respectively.
gene expression assay
Real- time reverse transcription- PCR was performed 
using ViiA 7 Real- Time PCR System (Applied Biosys-
tems). The expression of housekeeping gene GAPDH 
was stable and did not show significant variation across 
the different time points and subject groups. The panel 
of inflammatory genes assessed included IL-6, TNFα, 
IL-1β, IL-18, IL-8, IL-10, transforming growth factor-β, 
Toll- like receptor 4, monocyte chemoattractant protein-
1, and nuclear factor kappa B (NF-κB) gene complex, 
that is, Rel- A (p65 subunit of NF-κB), p105 (precursor 
of p50 subunit of NF-κB), IκB-α and IκB-β (inhibitors of 
NF-κB). The panel of oxidative stress genes examined 
included NRF2, GPX3, TXN, TXNRD1, SOD1, SOD2, 
CYBA, CYBB, NCF-1, NCF-2 and NCF-4.
Reduced/oxidized glutathione ratio detection assay
Following 7 days of differentiation and 10–30 min of 
insulin stimulation, cells (adipocytes and myotubes) 
were washed, lifted, lysed and deproteinized (catalog 
number 204708, Abcam, Cambridge, UK). Reduced/
oxidized glutathione (GSH/GSSG) ratio detection assay 
was performed subsequently using cell lysates (catalog 
number 205811, Abcam). GSH and GSSG were quantified 
on a fluorescent microplate reader at excitation/emis-
sion wavelength set to 490/520 nm. Absolute amounts of 
GSH and GSSG were determined using GSH and GSSG 
standard curves.
Western blots
Western blot was carried out from differentiated adipo-
cytes and myotubes derived from a subset of individuals 
undergoing the meal challenge, subject to availability 
of tissue biopsies. NE- PER Nuclear and Cytoplasmic 
Extraction Kit (Thermo Scientific, Rockford, IL, USA) 
was used for protein isolation according to the manu-
facturer’s protocol. Concentration of protein lysates was 
determined using Bradford assay reagent (Bio- Rad Labo-
ratories, Hercules, CA, USA).
Cytosolic and nuclear lysates (30 µg) were resolved 
by 4%–20% Mini- PROTEAN polyacrylamide gradient 
gel (Bio- Rad Laboratories) electrophoresis. Separated 
proteins were then transferred to PolyVinylidene DiFlu-
oride (PVDF) membranes (Bio- Rad Laboratories) and 
blocked with StartingBlock Blocking Buffer (Thermo 
Scientific) for 1 hour. Membranes were incubated over-
night at 4°C with the following antibodies: Anti- NRF2 
mAb (catalog number 12721; Cell Signaling Technology, 
Danvers, MA, USA), Anti- NF-κB p65 mAb (catalog number 
32536; Abcam), Anti- GAPDH mAb (catalog number 
5174; Cell Signaling Technology), and Anti- Histone H3 
mAb (catalog number 4499, Cell Signaling Technology). 
Thereafter, membranes were incubated with appropriate 
secondary horseradish peroxidase- conjugated antibodies 
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Age (years) 29.3 (2.50) 32.7 (2.90) 0.396
BMI (kg/m2) 25.7 (0.50) 24.8 (0.50) 0.273
Fasting blood glucose 
(mmol/L)
4.96 (0.14) 4.70 (0.14) 0.223
Fasting serum insulin 
(mU/L)
8.68 (1.20) 7.87 (2.03) 0.735
Fasting total cholesterol 
(mmol/L)
4.76 (0.26) 4.55 (0.25) 0.562
Fasting triglyceride 
(mmol/L)
0.87 (0.10) 1.00 (0.17) 0.508
Fasting LDL- cholesterol 
(mmol/L)
3.02 (0.24) 2.94 (0.26) 0.834
Fasting HDL- cholesterol 
(mmol/L)
1.35 (0.11) 1.15 (0.05) 0.119
Fasting NEFA (mmol/L) 0.78 (0.27) 0.52 (0.08) 0.371
HOMA- IR 1.94 (0.31) 1.69 (0.47) 0.662
Data are mean±SEM. Statistical significance was set at p<0.05 using 
t- test.
BMI, body mass index; FDRT, first- degree relative with type 2 diabetes 
mellitus; HDL, high- density lipoprotein; HOMA- IR, homeostatic model 
assessment of insulin resistance; LDL, low- density lipoprotein; NEFA, 
non- esterified fatty acid.
(Bio- Rad Laboratories) for 2 hours in blocking solution, 
subsequent to washing in PBST.
Proteins of interest were visualized by enhanced 
chemiluminescence (Millipore, Billerica, MA, USA) and 
exposed to imaging film. Molecular sizes of targets were 
estimated using prestained protein ladder (Thermo, 
Rockford, IL, USA). Signal intensities were quantified by 
density analysis using ImageJ software.
genetic loci analysis
We retrieved a list of T2DM susceptibility genetic loci 
(178 BMI- unadjusted loci and 10 BMI- adjusted loci) in 
East- Asian meta- analyses.31 We determined if any of these 
188 T2DM susceptibility genetic loci were cis- expression 
quantitative trait loci (eQTL) or in linkage disequilib-
rium (LD) with cis- eQTLs for the panel of inflammatory 
and oxidative stress genes included in this study, from 
Genome- Tissue Expression (GTEx) repository (https://
www. gtexportal. org/ home/). Cis- eQTLs in GTEx were 
determined as those with p<5×10−8 in any of the 44 
tissues.32 LD between T2DM genome- wide association 
study (GWAS) susceptibility single- nucleotide polymor-
phisms (SNP) and cis- eQTLs were assessed using East- 
Asian reference panel from the 1000 Genomes database 
(http:// grch37. ensembl. org/ index. html) and an r2>0.8 
was used to call loci that were in LD.
statistical analysis
The primary outcome in this study was the change (from 
fasting to postprandial) in transcription of oxidative 
stress genes regulated by NRF2 in MNC, as an indicator 
of NRF2 transcriptional activity and binding. Post hoc 
power calculation was based on the postprandial NRF2 
expression in terms of mean fold changes in FDRT and 
non- FDRT groups, in which a sample size of nine subjects 
per group showed the study power of detecting the differ-
ence between the two groups to be 85% at the 5% signif-
icance level.
The incremental area under the curve was computed 
using the trapezoidal method. A linear mixed model was 
used to analyze the differences in expression of genes in 
MNC following the meal challenge by group and time. 
Repeated measures analysis of variance was used to 
analyze the differences in all other variables with time 
series following meal challenge or insulin stimulation 
(levels of F2- isoprostanes, GSH, and expression of genes 
in myotubes/adipocytes), by group and time. Indepen-
dent samples t- test was used to analyze the differences in 




Demographic and metabolic parameters at baseline 
were not significantly different between groups (table 1; 
online supplementary database 1).
glucose, insulin, Tg and neFa trajectories following meal 
challenge
Postprandial incremental glucose, insulin, TG and NEFA 
responses were not different between the FDRT and non- 
FDRT groups following a carbohydrate- rich liquid mixed 
meal challenge (online supplementary table 1; online 
supplementary database 1).
oxidative stress response in circulating mnCs and plasma 
following a carbohydrate-rich liquid mixed meal challenge in 
FdRT and non-FdRT subjects
The expression of oxidative stress genes in MNCs 
during the fasting state was not significantly different 
between groups, with the exception of GPX3, which 
was lower in FDRT- derived MNC compared with non- 
FDRT- derived MNC (p<0.05) (online supplementary 
table 2). There were trends for greater expression of 
most pro- oxidant genes such as NCF-1, NCF-2, NCF-4, 
and CYBB (p≤0.1) in FDRT- derived MNC compared 
with non- FDRT- derived MNC following the meal chal-
lenge (table 2; figure 1A). By contrast, pro- oxidant 
gene CYBA showed a lower postprandial expression in 
the FDRT group (pgroup=0.027 and ptime×group=0.005). This 
occurred alongside marked postprandial upregulation 
in expression of antioxidant transcription factor NRF2 
(pgroup=0.002 and ptime×group=0.016) and its target genes 
GPX3 (pgroup=0.011 and ptime×group=0.019) and TXNRD1 
(pgroup=0.004 and ptime×group=0.007) in MNC from FDRT 
subjects compared with non- FDRT subjects (table 2; 
figure 1B). In addition, antioxidant gene SOD-1 showed 
a significant increase in postprandial expression in the 
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Table 2 Fold changes in oxidative gene expression in MNC at 2 and 6 hours in FDRT (n=9) and non- FDRT (n=9) subjects after 
a meal challenge
Δ 2 hours Δ 6 hours Group Time Interaction
Pro- oxidant genes NCF-1 FDRT 1.09±0.06 1.29±0.14 0.080 0.075 0.090
Non- FDRT 0.99±0.04 1.00±0.08
NCF-2 FDRT 1.08±0.04 1.22±0.13 0.115 0.076 0.281
Non- FDRT 0.95±0.04 1.03±0.08
NCF-4 FDRT 1.12±0.05 1.37±0.14 0.131 0.024 0.093
Non- FDRT 1.07±0.05 1.06±0.12
CYBB FDRT 1.22±0.08 1.49±0.13 0.127 0.002 0.115
Non- FDRT 1.19±0.12 1.16±0.10
CYBA FDRT 0.97±0.04 0.96±0.04 0.027 0.001 0.005
Non- FDRT 1.12±0.04 1.01±0.08
Antioxidant genes NRF2 FDRT 1.13±0.06 1.51±0.16 0.002 0.005 0.016
Non- FDRT 0.91±0.05 1.01±0.08
GPX3 FDRT 1.12±0.09 3.18±0.68 0.011 0.001 0.019
Non- FDRT 0.75±0.11 1.42±0.26
TXNRD1 FDRT 1.32±0.10 1.97±0.21 0.004 0.001 0.007
Non- FDRT 0.99±0.13 1.14±0.16
TXN FDRT 1.09±0.06 1.26±0.08 0.340 0.115 0.189
Non- FDRT 1.10±0.10 1.03±0.13
SOD1 FDRT 1.20±0.04 1.39±0.14 0.046 0.078 0.191
Non- FDRT 1.02±0.12 1.04±0.14
SOD2 FDRT 1.14±0.09 1.18±0.10 0.156 0.262 0.275
Non- FDRT 1.04±0.06 0.99±0.07
Data are mean±SEM. P<0.05 using a linear mixed model. Numbers in bold represent significant values.
FDRT, first- degree relative with type 2 diabetes mellitus; MNC, mononuclear cell.
FDRT group (pgroup=0.046 and ptime×group=0.191) (table 2; 
figure 1B).
There was no significant difference in plasma and 
urinary F2- isoprostane levels between groups in the fasted 
and postprandial states (online supplementary table 2; 
online supplementary figure 1). The relevant source data 
is available in online supplementary database 2.
Comparison of oxidative stress responses to insulin stimulus 
in myotubes and adipocytes isolated from FdRT and non-
FdRT subjects
To assess the effects of a high- carbohydrate meal chal-
lenge in cells derived from other metabolic tissues, 
adipocytes and myotubes from the FDRT and non- FDRT 
subjects were exposed to a 10 and 30 min insulin stim-
ulus (100 nM) in vitro. Overall there were trends for a 
greater expression of antioxidant genes following insulin 
stimulation in FDRT- derived myotubes compared with 
myotubes derived from non- FDRT subjects (p≤0.1 for 
TXN and NRF2) (online supplementary table 3). Syner-
gistically, expression of both pro- oxidant and antioxidant 
genes increased in FDRT- derived adipocytes (p≤0.05 
for CYBB and NCF-1; ptime×group=0.029 for TXN) (online 
supplementary table 3).
Baseline oxidative stress protein levels were not 
different between groups (online supplementary table 
2), but expression of antioxidant transcription factor 
NRF2 protein was greater following insulin stimulation 
in FDRT- derived than non- FDRT- derived myotubes 
(p<0.01) (figure 2). Adipocyte responses between the 
two groups did not differ significantly (online supple-
mentary figure 2).
GSH levels and GSH/GSSG ratio were not different 
between groups (online supplementary figure 3). The 
relevant source data is available online supplementary 
database 2.
Inflammatory response in circulating mnCs and plasma 
following a carbohydrate-rich liquid mixed meal challenge in 
FdRT and non-FdRT subjects
The baseline gene expression of IL-10 and IL-6 was lower 
in FDRT- derived MNC compared with non- FDRT- derived 
MNC (p<0.05), but expression of other genes did not 
differ significantly between groups (online supplemen-
tary table 2). The meal challenge induced greater expres-
sion of TNFα (pgroup=0.001 and ptime×group=0.007) in MNC 
derived from FDRT compared with MNC from non- FDRT 
subjects (table 3; figure 3). In addition, IL-6 (pgroup=0.089) 
and IL-10 (pgroup=0.057 and ptime×group=0.077) showed a 
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Figure 1 Fold changes from baseline in expression of 
genes involved in oxidative stress pathway in mononuclear 
cells (MNC) up to 6 hours following a high- carbohydrate meal 
challenge in first- degree relative with type 2 diabetes mellitus 
(FDRT; red circle) and non- FDRT (blue square) subjects. (A) 
Pro- oxidant genes. Significant or near- significant differential 
responses, as analyzed by linear mixed model, were found 
after meal ingestion in expression of: CYBA (pgroup=0.027 
and ptime×group=0.005), NCF-1 (pgroup=0.080 and ptime×group 
=0.090), NCF-2 (pgroup=0.115 and ptime×group=0.281), NCF-4 
(pgroup=0.131 and ptime×group=0.093), and CYBB (pgroup=0.127 
and ptime×group=0.115). (B) Antioxidant genes. Significant 
differential responses, as analyzed by linear mixed model, 
were found after meal ingestion in expression of: NRF2 
(pgroup=0.002 and ptime×group=0.016), GPX3 (pgroup=0.011 and 
ptime×group=0.019), TXNRD1 (pgroup=0.004 and ptime×group=0.007), 
and SOD1 (pgroup=0.046 and ptime×group=0.191). Data are 
mean±SEM. P<0.05.
Figure 2 Changes in expression of oxidant transcription 
factor NRF2 in myotubes, assessed by western blot assay. 
(A) Representative western blot (n=5) of basal and insulin 
(1000 nM for 30 min) stimulated levels of nuclear NRF2, 
assessed in myotubes from FDRT and non- FDRT subjects. 
(B) Densitometry analysis of western blot. Bars represent 
relative expression levels of nuclear NRF2 band intensity 
(n=5), normalized to respective basal levels, in FDRT (black 
bar) and non- FDRT (white bar) subjects. Data are mean±SEM 
(¶p<0.01 using t- test). FDRT, first- degree relative with type 2 
diabetes mellitus; NFDRT, non- FDRT.
near- significant increase in postprandial expression in 
the FDRT group.
Plasma levels of IL-6 did not differ between groups in 
the fasted and postprandial states (online supplementary 
table 2 and table 3), while plasma TNFα was generally 
undetectable (data not shown). The relevant source data 
is available in online supplementary database 3.
Comparison of inflammatory responses to insulin stimulus in 
myotubes and adipocytes isolated from FdRT and non-FdRT 
subjects
There were minimal changes in expression of inflam-
matory genes between FDRT and non- FDRT- derived 
myotubes following insulin stimulation (online supple-
mentary table 4). By contrast, whereas expression of 
proinflammatory genes showed a near- significant increase 
in FDRT- derived adipocytes (pgroup and ptime×group≤0.1 for 
TNFα), expression of anti- inflammatory genes did not 
(online supplementary table 4).
Baseline protein levels were not significantly different 
between groups (online supplementary table 2), but 
expression of inflammatory transcription factor NF-κB 
protein was greater in the non- FDRT- derived myotubes 
compared with the FDRT- derived myotubes following 
insulin stimulation (p<0.05) (online supplementary 
figure 4). Adipocyte responses between the two groups 
did not differ significantly (online supplementary figure 
5). The relevant source data is available in online supple-
mentary database 3.
genetic loci analysis
We examined whether T2DM susceptibility genetic loci 
were associated with the expression of inflammatory 
and oxidative stress genes that were found to be differ-
entially expressed between the FDRT and non- FDRT 
subjects. Using data from GTEx, we found that none of 
the reported 188 T2DM susceptibility genetic loci in East 
Asians are cis- eQTLs for our panel of inflammatory and 
oxidative stress genes (online supplementary database 4 
for GTEx data for T2DM susceptibility genetic loci in East 
Asians). Additionally, we identified 39 variants that are at 
LD with the T2DM susceptibility genetic loci but none of 
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Table 3 Fold changes in inflammatory gene expression in MNC and plasma IL-6 at 2 and 6 hours in FDRT (n=9) and non- 
FDRT (n=9) subjects after a meal challenge
Δ 2 hours Δ 6 hours Group Time Group×time
Proinflammatory 
genes
TNFα FDRT 1.36±0.10 1.80±0.16 0.001 0.001 0.007
Non- FDRT 1.06±0.08 1.17±0.07
IL-6 FDRT 1.33±0.56 6.73±2.38 0.089 0.002 0.153
Non- FDRT 0.56±0.16 2.68±0.89
MCP-1 FDRT 0.99±0.20 5.16±2.06 0.116 0.005 0.159
Non- FDRT 0.61±0.09 2.00±0.37
TLR4 FDRT 1.03±0.08 1.34±0.12 0.397 0.001 0.417
Non- FDRT 1.02±0.07 1.19±0.06
IL-1β FDRT 0.91±0.08 1.30±0.20 0.916 0.008 0.817
Non- FDRT 0.96±0.07 1.22±0.08
NF-κB/p105 FDRT 1.00±0.07 1.11±0.06 0.209 0.741 0.106
Non- FDRT 0.99±0.05 0.93±0.07
Rel- A FDRT 1.00±0.05 1.39±0.15 0.112 0.001 0.220
Non- FDRT 0.90±0.06 1.13±0.07
Anti- inflammatory 
genes
IκB-β FDRT 1.00±0.09 1.64±0.29 0.137 0.001 0.355
Non- FDRT 0.89±0.04 1.26±0.11
IκB-α FDRT 0.89±0.03 1.03±0.05 0.781 0.005 0.254
Non- FDRT 0.92±0.05 0.97±0.04
IL-10 FDRT 1.54±0.33 8.94±3.43 0.057 0.004 0.077
Non- FDRT 0.72±0.19 2.57±0.67
TGFβ FDRT 1.04±0.04 1.09±0.07 0.114 0.004 0.114
Non- FDRT 1.24±0.12 1.31±0.13
Cytokine IL-6
(plasma)
FDRT 0.64±0.16 1.02±0.13 0.349 0.001 0.606
Non- FDRT 0.43±0.10 0.98±0.18
Data are mean±SEM. P<0.05 using a linear mixed model. Numbers in bold represent significant values.
FDRT, first- degree relative with type 2 diabetes mellitus; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; MNC, mononuclear 
cell; NF-κB, nuclear factor kappa B; TGFβ, transforming growth factor-β; TLR4, Toll- like receptor 4; TNFα, tumor necrosis factor alpha.
these variants are cis- eQTLs for our panel of inflamma-
tory and oxidative stress genes.
dIsCussIon
We found that individuals with heredity of T2DM have 
increased inflammatory and oxidative stress responses 
to a high- carbohydrate meal challenge, independent of 
age, BMI and insulin sensitivity. Interestingly, there were 
no differences between FDRT and non- FDRT individuals 
in a variety of inflammatory and oxidative stress markers 
measured in the fasting state. These observations high-
light the importance of using a dynamic challenge (eg, 
meal) to unravel defects in physiological regulation and 
function.
FDRT individuals are known to be more insulin resis-
tant, metabolically inflexible, and have greater circu-
lating NEFA concentrations33–35 compared with their 
non- FDRT counterparts. Despite the strong association 
of heritability of T2DM with future risk of T2DM, the 
majority of this excess risk remain unexplained by major 
T2DM risk factors such as anthropometric measures, 
lifestyle factors and genetic risk scores.17 Emerging key 
players in T2DM pathophysiology such as adverse oxida-
tive stress and inflammatory responses could be among 
possible mechanisms that predispose FDRTs to develop 
T2DM. To our knowledge, this is the first report of a 
detailed characterization of inflammatory and oxida-
tive stress responses following a high- carbohydrate meal 
challenge and insulin stimulation, in association with 
heredity of T2DM.
Oxidative stress, a persistent imbalance between reactive 
oxygen species (ROS) and/or reactive nitrogen species 
and antioxidant defenses, damages DNA and proteome 
with adverse effects on many cellular functions.36 Our 
results in MNC demonstrate that heredity of T2DM is 
associated with increased postprandial inflammatory and 
oxidative stress responses. This has been suggested to 
be one of the earlier defects in atherogenic processes, 
and may thus increase risk of cardiovascular disease in 
these individuals.37 38 It is known that circulating immune 
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Figure 3 Fold changes from baseline in expression of genes involved in inflammatory pathway in mononuclear cells (MNC) 
up to 6 hours following a high- carbohydrate meal challenge in first- degree relative with type 2 diabetes mellitus (FDRT; red 
circle) and non- FDRT (blue square) subjects. Significant or near- significant differential responses, as analyzed by linear mixed 
model, were found after meal ingestion in expression of: TNFα (pgroup=0.001 and ptime×group=0.007), IL-6 (pgroup=0.089 and 
ptime×group=0.153), IL-10 (pgroup=0.057 and ptime×group=0.077), TGFβ (pgroup=0.114 and ptime×group=0.114), and MCP-1 (pgroup=0.131 and 
ptime×group=0.093). Data are mean±SEM. P<0.05. IL, interleukin; MCP-1, monocyte chemoattractant protein-1; NF-κB, nuclear 
factor kappa B; TGFβ, transforming growth factor-β; TLR4, Toll- like receptor 4; TNFα, tumor necrosis factor alpha.
cells (neutrophils and monocytes) in overnight fasted, 
overweight insulin- resistant individuals with a heredity 
of T2DM are in a pro- oxidative, proinflammatory state.20 
This was evident by significant upregulation of plasma 
levels of TNFα, IL-6 as well as myeloperoxidase, an ROS- 
generating enzyme that is known to strongly correlate 
with increased risk for cardiovascular and inflammatory 
diseases.39 40
Assessment of the oxidative stress genes in MNC 
revealed trends towards a higher pro- oxidative post-
prandial response in FDRT than non- FDRT subjects. 
This occurred alongside significant upregulation in the 
expression of antioxidant transcription factor NRF2 at 
the gene and protein levels as well as its target genes 
in FDRT subjects compared with non- FDRT subjects 
following the high- carbohydrate meal. Plasma and 
urinary F2- isoprostanes showed no differences between 
groups in the fasted and postprandial states. These results 
may demonstrate the adaptive homeostatic responses to a 
nutritional challenge, as orchestrated by the antioxidant 
and anti- inflammatory stress defenses. However, such 
compensatory mechanisms could be overwhelmed with 
persistent and progressive hyperglycemia and hyperlip-
idemia in FDRT individuals, leading to a decompensated 
and irreversible disease state, that is, T2DM and its 
complications.
In the current study, a high- carbohydrate meal induced 
an overall greater postprandial proinflammatory 
response in MNC from FDRT subjects as evident by the 
marked upregulation of TNFα after meal ingestion. This 
was accompanied by a compensatory rise in expression 
of anti- inflammatory genes such as IL-10, presumably 
to mitigate inflammatory cellular damage. It is known 
that oxidative stress culminates in activation of many 
stress- sensitive signaling pathways including the NF-κB- 
mediated inflammatory pathway. This in turn may lead to 
impaired insulin signaling and glucose transport activity 
associated with metabolic dysregulation states, including 
the development and progression of T2DM.6 41–44 Of 
note, despite marked upregulation of TNFα gene, a 
greater expression of its classical regulator—transcrip-
tion factor NF-κB—at gene and protein levels was not 
observed in this study. It is known that transcriptional 
regulation of expression of TNFα, an early gene rapidly 
transcribed after cellular activation by inflammatory or 
stress signaling, could be independent of NF-κB.45 For 
example, proteins of signal transducer and activator of 
transcription families are involved in activation of TNFα 
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gene transcription46 which is also reported to be specific 
to cell type and stimulus.47 Perhaps this could explain why 
the expressions of NF-κB and TNFα between myotube 
after insulin stimulation and MNC after meal intake were 
not aligned in our study.
We found that in vitro insulin stimulation exerts a 
modulating effect on the expression of inflammatory and 
oxidative stress genes on myotubes and adipocytes. This 
was evidenced by higher antistress defenses in response 
to higher stress in myotubes. However, GSH levels and 
reduced versus oxidized GSH ratio were not different 
between FDRT and non- FDRT groups. Aguer et al inves-
tigated the adaptive responses to oxidative stress in 
primary myotubes from obese individuals with heredity 
of T2DM.48 On exposure to chronic high- glucose and 
insulin conditions, there was an increase in antioxidant 
defenses (SOD2 expression and uncoupled respiration) 
in myotubes derived from FDRT individuals, similar to 
our findings. Further, oxidative stress level did not differ 
in myotubes between groups. These observations may 
represent adaptive homeostatic responses to a physio-
logical challenge in otherwise healthy normoglycemic 
individuals.
In this study, we demonstrated that currently known 
T2DM susceptibility genetic loci in East Asians had no 
association with the differential expression of inflamma-
tory and oxidative stress genes. However, there may be 
other common and/or rare variants that are associated 
with these gene expression profiles, which remain to be 
characterized. Furthermore, post- translational and chro-
matin modifications are emerging as critical mediators in 
pathogenesis of oxidative stress and inflammation in the 
context of T2DM and may be contributing factors to the 
development of disease.49
To our knowledge, detailed changes in postprandial 
inflammatory and oxidative stress have not been assessed 
previously in association with heredity of T2DM. We 
studied the effects of a high- carbohydrate meal with a 
caloric content and macronutrient composition well 
representative of normal dietary intake, as opposed to 
high- fat meals used in previous studies.21 22 We were able 
to observe significant differences in several but not all of 
biomarkers of stress- activated signaling pathways exam-
ined. It should be noted that, other than heredity of 
T2DM, all our subjects were otherwise healthy and normo-
glycemic and therefore capable of adaptive homeostatic 
responses. This may have led to the modest changes in a 
number of biomarkers observed in this study.
ConClusIons
Our findings shed light on how heredity of T2DM is 
associated with increased susceptibility to oxidative stress 
and inflammation in the postprandial state, which may 
predispose FDRT individuals to T2DM and its associated 
complications. Findings from this study contribute to 
forming the basis for large, prospective cohort studies 
delineating novel factors specifically contributing to 
conversion to T2DM. Further, interventional studies and 
novel therapeutic approaches targeting these stress path-
ways could be envisioned.
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